{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:12:48Z","timestamp":1793643168499,"version":"4.5.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T00:00:00Z","timestamp":1552262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T00:00:00Z","timestamp":1552262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Understanding the dynamics of the immune response following late myocardial reperfusion is critical for the development of immunomodulatory therapy for myocardial infarction (MI). Cyclosporine A (CSA) possesses multiple therapeutic applications for MI, but its effects on the inflammation caused by acute MI are not clear. This study aimed to determine the dynamics of the immune response following myocardial ischemia\/reperfusion (I\/R) and the effects of CSA in a mouse model of prolonged myocardial ischemia designated to represent the human condition of late reperfusion. Adult C57BL\/6 mice were subjected to 90\u2009min of closed-chest myocardial I\/R, which induced severe myocardial injury and excessive inflammation in the heart. Multicomponent analysis of the immune response caused by prolonged I\/R revealed that the peak of cytokines\/chemokines in the systemic circulation was synchronized with the maximal influx of neutrophils and T-cells in the heart 1 day after MI. The peak of cytokine\/chemokine secretion in the infarcted heart coincided with the maximal macrophage and natural killer cell infiltration on day 3 after MI. The cellular composition of the mediastinal lymph nodes changed similarly to that of the infarcted hearts. CSA (10\u2009mg\/kg\/day) given after prolonged I\/R impaired heart function, enlarged the resulting scar, and reduced heart vascularization. It did not change the content of immune cells in hearts exposed to prolonged I\/R, but the levels of MCP-1 and MIP-1\u03b1 (hearts) and IL-12 (hearts and serum) were significantly reduced in the CSA-treated group in comparison to the untreated group, indicating alterations in immune cell function. Our findings provide new knowledge necessary for the development of immunomodulatory therapy targeting the immune response after prolonged myocardial ischemia\/reperfusion.<\/jats:p>","DOI":"10.1038\/s41401-018-0197-1","type":"journal-article","created":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T13:02:49Z","timestamp":1552309369000},"page":"1168-1183","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Temporal dynamics of immune response following prolonged myocardial ischemia\/reperfusion with and without cyclosporine A"],"prefix":"10.1038","volume":"40","author":[{"given":"Vitali","family":"Rusinkevich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Qiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-fang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huang-tian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,11]]},"reference":[{"key":"197_CR1","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1093\/eurheartj\/ehp113","volume":"30","author":"M Busk","year":"2009","unstructured":"Busk M, Kaltoft A, Nielsen SS, Bottcher M, Rehling M, Thuesen L, et al. Infarct size and myocardial salvage after primary angioplasty in patients presenting with symptoms for <12 h vs. 12-72 h. Eur Heart J. 2009;30:1322\u201330.","journal-title":"Eur Heart J"},{"key":"197_CR2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/clc.22356","volume":"38","author":"Y Fan","year":"2015","unstructured":"Fan Y, Bai X, Chen Y, Shen G, Lu Q, Wan Z, et al. Late percutaneous coronary intervention prevents left ventricular remodeling and improves clinical outcomes in patients with ST-elevation myocardial infarction. Clin Cardiol. 2015;38:82\u201391.","journal-title":"Clin Cardiol"},{"key":"197_CR3","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1161\/01.CIR.88.5.2426","volume":"88","author":"CB Kim","year":"1993","unstructured":"Kim CB, Braunwald E. Potential benefits of late reperfusion of infarcted myocardium. The open artery hypothesis. Circulation. 1993;88:2426\u201336.","journal-title":"Circulation"},{"key":"197_CR4","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1161\/CIRCRESAHA.108.177568","volume":"103","author":"M Nakagawa","year":"2008","unstructured":"Nakagawa M, Takemura G, Kanamori H, Goto K, Maruyama R, Tsujimoto A, et al. Mechanisms by which late coronary reperfusion mitigates postinfarction cardiac remodeling. Circ Res. 2008;103:98\u2013106.","journal-title":"Circ Res"},{"key":"197_CR5","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/cvr\/cvp032","volume":"83","author":"G Takemura","year":"2009","unstructured":"Takemura G, Nakagawa M, Kanamori H, Minatoguchi S, Fujiwara H. Benefits of reperfusion beyond infarct size limitation. Cardiovasc Res. 2009;83:269\u201376.","journal-title":"Cardiovasc Res"},{"key":"197_CR6","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.ijcard.2014.11.006","volume":"179","author":"SC Latet","year":"2015","unstructured":"Latet SC, Hoymans VY, Van Herck PL, Vrints CJ. The cellular immune system in the post-myocardial infarction repair process. Int J Cardiol. 2015;179:240\u20137.","journal-title":"Int J Cardiol"},{"key":"197_CR7","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1161\/CIRCRESAHA.116.304072","volume":"116","author":"U Hofmann","year":"2015","unstructured":"Hofmann U, Frantz S. Role of lymphocytes in myocardial injury, healing, and remodeling after myocardial infarction. Circ Res. 2015;116:354\u201367.","journal-title":"Circ Res"},{"key":"197_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","volume":"119","author":"SD Prabhu","year":"2016","unstructured":"Prabhu SD, Frangogiannis NG. The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis. Circ Res. 2016;119:91\u2013112.","journal-title":"Circ Res"},{"key":"197_CR9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nri3800","volume":"15","author":"S Epelman","year":"2015","unstructured":"Epelman S, Liu PP, Mann DL. Role of innate and adaptive immune mechanisms in cardiac injury and repair. Nat Rev Immunol. 2015;15:117\u201329.","journal-title":"Nat Rev Immunol"},{"key":"197_CR10","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/nrd.2017.106","volume":"16","author":"TJ Cahill","year":"2017","unstructured":"Cahill TJ, Choudhury RP, Riley PR. Heart regeneration and repair after myocardial infarction: translational opportunities for novel therapeutics. Nat Rev Drug Discov. 2017;16:699\u2013717.","journal-title":"Nat Rev Drug Discov"},{"key":"197_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.yjmcc.2013.04.023","volume":"62","author":"X Yan","year":"2013","unstructured":"Yan X, Anzai A, Katsumata Y, Matsuhashi T, Ito K, Endo J, et al. Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarction. J Mol Cell Cardiol. 2013;62:24\u201335.","journal-title":"J Mol Cell Cardiol"},{"key":"197_CR12","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s12265-014-9570-8","volume":"7","author":"SJ Jansen Of Lorkeers","year":"2014","unstructured":"Jansen Of Lorkeers SJ, Hart E, Tang XL, Chamuleau ME, Doevendans PA, Bolli R, et al. Cyclosporin in cell therapy for cardiac regeneration. J Cardiovasc Transl Res. 2014;7:475\u201382.","journal-title":"J Cardiovasc Transl Res"},{"key":"197_CR13","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/stem.580","volume":"29","author":"Q Xiong","year":"2011","unstructured":"Xiong Q, Hill KL, Li Q, Suntharalingam P, Mansoor A, Wang X, et al. A fibrin patch\u2010based enhanced delivery of human embryonic stem cell\u2010derived vascular cell transplantation in a porcine model of postinfarction left ventricular remodeling. Stem Cells. 2011;29:367\u201375.","journal-title":"Stem Cells"},{"key":"197_CR14","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1161\/CIRCRESAHA.117.311578","volume":"122","author":"K Zhu","year":"2018","unstructured":"Zhu K, Wu Q, Ni C, Zhang P, Zhong Z, Wu Y, et al. Lack of remuscularization following transplantation of human embryonic stem cell-derived cardiovascular progenitor cells in infarcted nonhuman primates. Circ Res. 2018;122:958\u201369.","journal-title":"Circ Res"},{"key":"197_CR15","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1093\/cvr\/27.10.1790","volume":"27","author":"MR Duchen","year":"1993","unstructured":"Duchen MR, McGuinness O, Brown LA, Crompton M. On the involvement of a cyclosporin A sensitive mitochondrial pore in myocardial reperfusion injury. Cardiovasc Res. 1993;27:1790\u20134.","journal-title":"Cardiovasc Res"},{"key":"197_CR16","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1124\/jpet.109.153213","volume":"330","author":"S Javadov","year":"2009","unstructured":"Javadov S, Karmazyn M, Escobales N. Mitochondrial permeability transition pore opening as a promising therapeutic target in cardiac diseases. J Pharmacol Exp Ther. 2009;330:670\u20138.","journal-title":"J Pharmacol Exp Ther"},{"key":"197_CR17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s00395-015-0475-8","volume":"110","author":"J Zalewski","year":"2015","unstructured":"Zalewski J, Claus P, Bogaert J, Driessche NV, Driesen RB, Galan DT, et al. Cyclosporine A reduces microvascular obstruction and preserves left ventricular function deterioration following myocardial ischemia and reperfusion. Basic Res Cardiol. 2015;110:18.","journal-title":"Basic Res Cardiol"},{"key":"197_CR18","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1056\/NEJMoa1505489","volume":"373","author":"TT Cung","year":"2015","unstructured":"Cung T-T, Morel O, Cayla G, Rioufol G, Garcia-Dorado D, Angoulvant D, et al. Cyclosporine before PCI in patients with acute myocardial Infarction. New Engl J Med. 2015;373:1021\u201331.","journal-title":"New Engl J Med"},{"key":"197_CR19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/cphy.c160006","volume":"7","author":"T Kalogeris","year":"2016","unstructured":"Kalogeris T, Baines CP, Krenz M, Korthuis RJ. Ischemia\/reperfusion. Compr Physiol. 2016;7:113\u201370.","journal-title":"Compr Physiol"},{"key":"197_CR20","doi-asserted-by":"publisher","first-page":"H1049","DOI":"10.1152\/ajpheart.2000.278.4.H1049","volume":"278","author":"TO Nossuli","year":"2000","unstructured":"Nossuli TO, Lakshminarayanan V, Baumgarten G, Taffet GE, Ballantyne CM, Michael LH, et al. A chronic mouse model of myocardial ischemia-reperfusion: essential in cytokine studies. Am J Physiol Heart Circ Physiol. 2000;278:H1049\u2013H1055.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"197_CR21","doi-asserted-by":"crossref","unstructured":"Kim SC, Boehm O, Meyer R, Hoeft A, Knufermann P, Baumgarten G. A murine closed-chest model of myocardial ischemia and reperfusion. J Vis Exp. 2012;65:e3896.","DOI":"10.3791\/3896"},{"key":"197_CR22","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1113\/eph8702385","volume":"87","author":"F Yang","year":"2002","unstructured":"Yang F, Liu YH, Yang XP, Xu J, Kapke A, Carretero OA. Myocardial infarction and cardiac remodelling in mice. Exp Physiol. 2002;87:547\u201355.","journal-title":"Exp Physiol"},{"key":"197_CR23","doi-asserted-by":"publisher","first-page":"e25045","DOI":"10.1371\/journal.pone.0025045","volume":"6","author":"DS Nascimento","year":"2011","unstructured":"Nascimento DS, Valente M, Esteves T, de Pina Mde F, Guedes JG, Freire A, et al. MIQuant\u2013semi-automation of infarct size assessment in models of cardiac ischemic injury. PLoS One. 2011;6:e25045.","journal-title":"PLoS One"},{"key":"197_CR24","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jim.2013.03.012","volume":"393","author":"AR Pinto","year":"2013","unstructured":"Pinto AR, Chandran A, Rosenthal NA, Godwin JW. Isolation and analysis of single cells from the mouse heart. J Immunol Methods. 2013;393:74\u201380.","journal-title":"J Immunol Methods"},{"key":"197_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.7","volume":"8","author":"Y Zheng","year":"2017","unstructured":"Zheng Y, Gu S, Li X, Tan J, Liu S, Jiang Y, et al. Berbamine postconditioning protects the heart from ischemia\/reperfusion injury through modulation of autophagy. Cell Death Dis. 2017;8:e2577.","journal-title":"Cell Death Dis"},{"key":"197_CR26","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/eurheartj\/ehv639","volume":"37","author":"U Hofmann","year":"2016","unstructured":"Hofmann U, Frantz S. Role of T-cells in myocardial infarction. Eur Heart J. 2016;37:873\u20139.","journal-title":"Eur Heart J"},{"key":"197_CR27","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1016\/j.celrep.2017.02.079","volume":"18","author":"K Van der Borght","year":"2017","unstructured":"Van der Borght K, Scott CL, Nindl V, Bouche A, Martens L, Sichien D, et al. Myocardial infarction primes autoreactive T-cells through activation of dendritic cells. Cell Rep. 2017;18:3005\u201317.","journal-title":"Cell Rep"},{"key":"197_CR28","doi-asserted-by":"crossref","first-page":"159","DOI":"10.59566\/IJBS.2007.3159","volume":"3","author":"H Morimoto","year":"2007","unstructured":"Morimoto H, Takahashi M. Role of Monocyte chemoattractant protein-1 in myocardial infarction. Int J Biomed Sci. 2007;3:159\u201367.","journal-title":"Int J Biomed Sci"},{"key":"197_CR29","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1124\/jpet.113.207316","volume":"347","author":"J Niu","year":"2013","unstructured":"Niu J, Wang K, Zhelyabovska O, Saad Y, Kolattukudy PE. MCP-1-induced protein promotes endothelial-like and angiogenic properties in human bone marrow monocytic cells. J Pharmacol Exp Ther. 2013;347:288\u201397.","journal-title":"J Pharmacol Exp Ther"},{"key":"197_CR30","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/cvr\/cvv255","volume":"109","author":"X Kan","year":"2016","unstructured":"Kan X, Wu Y, Ma Y, Zhang C, Li P, Wu L. et al. Deficiency of IL-12p35 improves cardiac repair after myocardial infarction by promoting angiogenesis. Cardiovasc Res. 2016;109:249\u201359.","journal-title":"Cardiovasc Res"},{"key":"197_CR31","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1093\/cvr\/cvu025","volume":"102","author":"S Frantz","year":"2014","unstructured":"Frantz S, Nahrendorf M. Cardiac macrophages and their role in ischaemic heart disease. Cardiovasc Res. 2014;102:240\u20138.","journal-title":"Cardiovasc Res"},{"key":"197_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.trsl.2017.10.001","volume":"191","author":"Y Ma","year":"2018","unstructured":"Ma Y, Mouton AJ, Lindsey ML. Cardiac macrophage biology in the steady-state heart, the aging heart, and following myocardial infarction. Transl Res. 2018;191:15\u201328.","journal-title":"Transl Res"},{"key":"197_CR33","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1161\/CIRCRESAHA.115.303567","volume":"115","author":"T Heidt","year":"2014","unstructured":"Heidt T, Courties G, Dutta P, Sager HB, Sebas M, Iwamoto Y, et al. Differential contribution of monocytes to heart macrophages in steady-state and after myocardial infarction. Circ Res. 2014;115:284\u201395.","journal-title":"Circ Res"},{"key":"197_CR34","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1369\/0022155413493912","volume":"61","author":"P Christia","year":"2013","unstructured":"Christia P, Bujak M, Gonzalez-Quesada C, Chen W, Dobaczewski M, Reddy A, et al. Systematic characterization of myocardial inflammation, repair, and remodeling in a mouse model of reperfused myocardial infarction. J Histochem Cytochem. 2013;61:555\u201370.","journal-title":"J Histochem Cytochem"},{"key":"197_CR35","doi-asserted-by":"publisher","first-page":"4552","DOI":"10.7150\/thno.24723","volume":"8","author":"TT Tang","year":"2018","unstructured":"Tang T-T, Li Y-Y, Li J-J, Wang K, Han Y, Dong W-Y, et al. Liver-heart crosstalk controls IL-22 activity in cardiac protection after myocardial infarction. Theranostics. 2018;8:4552\u201362.","journal-title":"Theranostics"},{"key":"197_CR36","doi-asserted-by":"publisher","first-page":"I27","DOI":"10.1093\/eurheartj\/sui077","volume":"7","author":"RF Bonvini","year":"2005","unstructured":"Bonvini RF, Hendiri T, Camenzind E. Inflammatory response post-myocardial infarction and reperfusion: a new therapeutic target? Eur Heart J Suppl. 2005;7:I27\u2013I36.","journal-title":"Eur Heart J Suppl"},{"key":"197_CR37","first-page":"305","volume":"12","author":"L Fang","year":"2015","unstructured":"Fang L, Moore XL, Dart AM, Wang LM. Systemic inflammatory response following acute myocardial infarction. J Geriatr Cardiol. 2015;12:305\u201312.","journal-title":"J Geriatr Cardiol"},{"key":"197_CR38","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00011-013-0605-4","volume":"62","author":"N Ruparelia","year":"2013","unstructured":"Ruparelia N, Digby JE, Jefferson A, Medway DJ, Neubauer S, Lygate CA, et al. Myocardial infarction causes inflammation and leukocyte recruitment at remote sites in the myocardium and in the renal glomerulus. Inflamm Res. 2013;62:515\u201325.","journal-title":"Inflamm Res"},{"key":"197_CR39","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/icb.2014.16","volume":"92","author":"M Pal","year":"2014","unstructured":"Pal M, Febbraio MA, Whitham M. From cytokine to myokine: the emerging role of interleukin-6 in metabolic regulation. Immunol Cell Biol. 2014;92:331\u20139.","journal-title":"Immunol Cell Biol"},{"key":"197_CR40","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/cr.2015.110","volume":"25","author":"C Han","year":"2015","unstructured":"Han C, Nie Y, Lian H, Liu R, He F, Huang H, et al. Acute inflammation stimulates a regenerative response in the neonatal mouse heart. Cell Res. 2015;25:1137\u201351.","journal-title":"Cell Res"},{"key":"197_CR41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10741-014-9431-1","volume":"20","author":"M Huang","year":"2015","unstructured":"Huang M, Yang D, Xiang M, Wang J. Role of interleukin-6 in regulation of immune responses to remodeling after myocardial infarction. Heart Fail Rev. 2015;20:25\u201338.","journal-title":"Heart Fail Rev"},{"key":"197_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-07524-x","volume":"7","author":"K Kobayashi","year":"2017","unstructured":"Kobayashi K, Maeda K, Takefuji M, Kikuchi R, Morishita Y, Hirashima M, et al. Dynamics of angiogenesis in ischemic areas of the infarcted heart. Sci Rep. 2017;7:7156.","journal-title":"Sci Rep"},{"key":"197_CR43","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/0014-5793(89)80590-3","volume":"244","author":"T Yoshimura","year":"1989","unstructured":"Yoshimura T, Yuhki N, Moore SK, Appella E, Lerman MI, Leonard EJ. Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS Lett. 1989;244:487\u201393.","journal-title":"FEBS Lett"},{"issue":"11","key":"197_CR44","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.3390\/ijms17111856","volume":"17","author":"Anisyah Ridiandries","year":"2016","unstructured":"Ridiandries A, Tan JT, Bursill CA. The role of CC-chemokines in the regulation of angiogenesis. Int J Mol Sci. 2016;17:e1856.","journal-title":"International Journal of Molecular Sciences"},{"key":"197_CR45","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1161\/CIRCULATIONAHA.111.036061","volume":"124","author":"BL Hoh","year":"2011","unstructured":"Hoh BL, Hosaka K, Downes DP, Nowicki KW, Fernandez CE, Batich CD, et al. Monocyte chemotactic protein-1 promotes inflammatory vascular repair of murine carotid aneurysms via a macrophage inflammatory protein-1alpha and macrophage inflammatory protein-2-dependent pathway. Circulation. 2011;124:2243\u201352.","journal-title":"Circulation"},{"key":"197_CR46","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1097\/shk.0b013e31814b8e0d","volume":"28","author":"M Frink","year":"2007","unstructured":"Frink M, Hsieh YC, Hsieh CH, Pape HC, Choudhry MA, Schwacha MG, et al. Keratinocyte-derived chemokine plays a critical role in the induction of systemic inflammation and tissue damage after trauma-hemorrhage. Shock. 2007;28:576\u201381.","journal-title":"Shock"},{"key":"197_CR47","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1093\/eurheartj\/ehr127","volume":"33","author":"F Montecucco","year":"2012","unstructured":"Montecucco F, Braunersreuther V, Lenglet S, Delattre BMA, Pelli G, Buatois V, et al. CC chemokine CCL5 plays a central role impacting infarct size and post-infarction heart failure in mice. Eur Heart J. 2012;33:1964\u201374.","journal-title":"Eur Heart J"},{"key":"197_CR48","first-page":"100","volume":"13","author":"M Sajedi Khanian","year":"2016","unstructured":"Sajedi Khanian M, Abdi Ardekani A, Khosropanah S, Doroudchi M. Correlation of early and late ejection fractions with CCL5 and CCL18 levels in acute anterior myocardial infarction. Iran J Immunol. 2016;13:100\u201313.","journal-title":"Iran J Immunol"},{"key":"197_CR49","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1161\/CIRCRESAHA.115.306557","volume":"116","author":"P Bernardi","year":"2015","unstructured":"Bernardi P, Di Lisa F, Fogolari F, Lippe G. From ATP to PTP and Back: a dual function for the mitochondrial ATP synthase. Circ Res. 2015;116:1850\u201362.","journal-title":"Circ Res"},{"key":"197_CR50","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.cardiores.2007.04.022","volume":"75","author":"SY Lim","year":"2007","unstructured":"Lim SY, Davidson SM, Hausenloy DJ, Yellon DM. Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore. Cardiovasc Res. 2007;75:530\u20135.","journal-title":"Cardiovasc Res"},{"key":"197_CR51","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00395-010-0124-1","volume":"105","author":"K Boengler","year":"2010","unstructured":"Boengler K, Hilfiker-Kleiner D, Heusch G, Schulz R. Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia\/reperfusion. Basic Res Cardiol. 2010;105:771\u201385.","journal-title":"Basic Res Cardiol"},{"key":"197_CR52","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1111\/j.1476-5381.2011.01691.x","volume":"165","author":"WY Lim","year":"2012","unstructured":"Lim WY, Messow CM, Berry C. Cyclosporin variably and inconsistently reduces infarct size in experimental models of reperfused myocardial infarction: a systematic review and meta-analysis. Br J Pharmacol. 2012;165:2034\u201343.","journal-title":"Br J Pharmacol"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-018-0197-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-018-0197-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-018-0197-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T17:54:17Z","timestamp":1721066057000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-018-0197-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,11]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["197"],"URL":"https:\/\/doi.org\/10.1038\/s41401-018-0197-1","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,11]]},"assertion":[{"value":"29 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}